Whichever drug and provider you choose, the medication is only ever half the plan
The data show that the combination of nasal anti-CD3 plus semaglutide improves liver homeostasis and reduces inflammation in models of diet-induced obesity (DIO), providing a potential novel approach to combat obesity-related inflammation, and liver inflammation and dysfunction
Obesity increases a persons risk of diabetes, high blood pressure, heart disease, cholesterol, cancer, asthma and so on
Pre-Treatment Provider Conversation: Key Questions Before starting semaglutide, discuss storage feasibility with your provider or prescribing clinician
Private Prescription Costs and Payment Options For patients who do not meet NHS eligibility criteria or face lengthy waiting times, private prescription options provide an alternative route to access Wegovy or Ozempic